India to Develop AI Solutions for Pre-Term Births

Why It Matters

Targeting a leading cause of neonatal death in a high‑burden market, locally‑trained AI models promise more accurate risk assessment than imported tools, potentially saving thousands of lives while spawning a new health‑tech ecosystem in India.

Key Takeaways

• 12,000 women enrolled, creating massive pregnancy dataset
• Over 1.6 million biospecimens and 1M ultrasound images collected
• AI models predict preterm birth risk tailored to Indian population
• National biorepository and GARBH‑INi‑DRISHTI platform enable data sharing
• Partnerships translate research into clinical tools like AI ultrasound

Pulse Analysis

Preterm birth remains the single biggest cause of neonatal mortality worldwide, accounting for roughly 15 percent of all births. India contributes a disproportionate share—over 20 percent of global preterm cases—driven by its large population and diverse health landscape. Conventional risk‑assessment tools, often trained on Western cohorts, miss critical genetic, microbiome and socioeconomic variables unique to Indian mothers. Recognizing this gap, the Ministry of Science and Technology has prioritized home‑grown artificial‑intelligence solutions that can ingest locally relevant data and deliver earlier, more precise warnings. Investments in digital health have surged, with AI startups receiving over $500 million in funding globally, underscoring the commercial appetite for such solutions.

The GARBH‑INi programme has now enrolled 12,000 pregnant women, producing more than 1.6 million biospecimens and over a million ultrasound images—the largest pregnancy‑centric dataset in South Asia. This trove fuels AI models that predict gestational age, identify microbiome signatures linked to preterm labor, and flag genetic markers for heightened risk. A national biorepository and the GARBH‑INi‑DRISHTI data‑sharing platform ensure researchers and startups can access the data securely. Partnerships with Qure.ai, Doto Health and Sundyota Numandis Probioceuticals are already converting algorithms into point‑of‑care diagnostics and automated ultrasound reporting tools.

The next phase aims to deploy these predictive models at scale across India’s public health network, integrating risk‑stratification into routine antenatal visits. By delivering earlier interventions, the programme could cut preterm‑birth rates by several percentage points, translating into thousands of lives saved and reduced long‑term health costs. Moreover, the success of a domestically sourced AI ecosystem positions India as a potential export hub for maternal‑health technologies, attracting venture capital and fostering cross‑border collaborations in Southeast Asia and beyond.